Cargando…

Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington’s Disease

BACKGROUND AND PURPOSE: Huntington’s disease (HD) is a chronic progressive neurodegenerative disorder with a long presymptomatic period that opens a window for potential therapies aimed at neuroprotection. Neuroimaging offers the potential to monitor disease-related progression of the disease burden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiest, Roland, Burgunder, Jean-Marc, Kiefer, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592228/ https://www.ncbi.nlm.nih.gov/pubmed/28932207 http://dx.doi.org/10.3389/fneur.2017.00465

Ejemplares similares

Translational research in Huntington’s disease: opening up for disease modifying treatment
por: Burgunder, Jean-Marc
Publicado: (2013)

Molecular Imaging Markers to Track Huntington’s Disease Pathology
por: Wilson, Heather, et al.
Publicado: (2017)

Magnetization transfer imaging in ‘premanifest’ Huntington’s disease
por: Jurgens, Caroline K., et al.
Publicado: (2009)

Huntington's like conditions in China, A review of published Chinese cases
por: Zheng, Zhenzhen, et al.
Publicado: (2012)

Analysis of the robustness and dynamics of spin-locking preparations for the detection of oscillatory magnetic fields
por: Capiglioni, Milena, et al.
Publicado: (2022)

Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
por: You, Huajing, et al.
Publicado: (2021)

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease
por: Burgunder, Jean-Marc, et al.
Publicado: (2011)

Quantification of Huntington’s Disease Related Markers in the R6/2 Mouse Model
por: Etxeberria-Rekalde, Estibaliz, et al.
Publicado: (2021)

Multiple Aspects of Gene Dysregulation in Huntington’s Disease
por: Moumné, Lara, et al.
Publicado: (2013)

Asymptomatic malaria carriers and their characterization in hotpops of malaria at Mangalore
por: Ramaswamy, Akash, et al.
Publicado: (2020)

Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers
por: Aasly, Jan O., et al.
Publicado: (2014)

The Impact of Upcoming Treatments in Huntington’s Disease: Resource Capacity Limitations and Access to Care Implications
por: Guttman, Mark, et al.
Publicado: (2021)

Calcium imaging: A versatile tool to examine Huntington’s disease mechanisms and progression
por: Barry, Joshua, et al.
Publicado: (2022)

Symptomatic treatment options for Huntington’s disease (guidelines of the German Neurological Society)
por: Saft, Carsten, et al.
Publicado: (2023)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Acanthocytes Identified in Huntington’s Disease
por: Yu, Yueyi, et al.
Publicado: (2022)

Metacognitive insight into cognitive performance in Huntington’s disease gene carriers
por: Hewitt, Samuel RC, et al.
Publicado: (2022)

Transductive Transfer Learning for Domain Adaptation in Brain Magnetic Resonance Image Segmentation
por: Kushibar, Kaisar, et al.
Publicado: (2021)

SLOW: A novel spectral editing method for whole‐brain MRSI at ultra high magnetic field
por: Weng, Guodong, et al.
Publicado: (2022)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Altered Cholesterol Homeostasis in Huntington’s Disease
por: Kacher, Radhia, et al.
Publicado: (2022)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Multimodal magnetic resonance imaging reveals distinct sensitivity of hippocampal subfields in asymptomatic stage of Alzheimer’s disease
por: Wu, Junjie, et al.
Publicado: (2022)

Neuronal current imaging: An experimental method to investigate electrical currents in dogs with idiopathic epilepsy
por: Unger, Daniela M., et al.
Publicado: (2021)

Corrigendum: Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Role of cerebral cortex in the neuropathology of Huntington's disease
por: Estrada-Sánchez, Ana M., et al.
Publicado: (2013)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Ubiquitin–proteasome system involvement in Huntington’s disease
por: Ortega, Zaira, et al.
Publicado: (2014)

Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease
por: Highet, Blake, et al.
Publicado: (2020)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021)

Pain in Huntington’s disease and its potential mechanisms
por: Li, Jiajie, et al.
Publicado: (2023)

Characterization of forebrain neurons derived from late-onset Huntington's disease human embryonic stem cell lines
por: Niclis, Jonathan C., et al.
Publicado: (2013)

Magnetization Transfer Ratio Relates to Cognitive Impairment in Normal Elderly
por: Seiler, Stephan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2kirg0kthmb6vsqn0k8u351qkr